Medline MDLN
NASDAQ MDLN
$34.26 +1.68 (+5.16%)
At close: Aug 21, 2026 · 4:00 PM EDT

Medline (MDLN) Other Non-Current Liabilities (2025 - 2026)

Medline (MDLN) posted quarterly Other Non-Current Liabilities of $4.0 billion for Q1 2026, up 489.59% quarter-over-quarter from $682.0 million in Q4 2025.

Medline (MDLN) Other Non-Current Liabilities (2025 - 2026) Analysis & Trends

Medline (MDLN) has reported Other Non-Current Liabilities for 2 consecutive years, with $4.0 billion the latest figure, recorded in Q1 2026.

  • In Q1 2026, Other Non-Current Liabilities changed N/A year-over-year to $4.0 billion; the TTM figure through Mar 2026 stood at $4.0 billion (changed N/A YoY), while the FY2025 annual figure was $682.0 million, changed N/A from the prior year.
  • Other Non-Current Liabilities climbed to $4.0 billion in Q1 2026 per MDLN's latest filing, from $682.0 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $4.0 billion in Q1 2026 and bottomed at $682.0 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 134.13 Bn 128.91 Bn 1.96 Bn
2 Becton Dickinson 52.76 Bn 51.90 Bn 2.32 Bn
3 Alcon 35.81 Bn 34.46 Bn 1.68 Bn
4 Resmed 33.72 Bn 32.25 Bn 861.22 Mn
5 Medline 29.38 Bn 26.70 Bn 2.22 Bn
6 West Pharmaceutical Services 25.00 Bn 24.57 Bn 329.20 Mn
7 Solventum 15.46 Bn 15.06 Bn 1.29 Bn
8 Cooper Companies 14.88 Bn 14.74 Bn 735.40 Mn
9 Baxter International 13.58 Bn 11.43 Bn 1.03 Bn
10 Align Technology 11.61 Bn 10.51 Bn 757.43 Mn

Historic Data

Download Data
DateValue
Jun 27, 2026 4.40 Bn
Mar 28, 2026 4.02 Bn
Dec 31, 2025 682.00 Mn